Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2

  • Post author:
  • Post category:uncategorized

The ongoing COVID-19 pandemic caused by SARS-CoV-2 has caused serious damage to public health and the global economy, and one strategy to combat COVID-19 has been the development of broadly neutralizing antibodies for prophylactic and therapeutic use.